Indian drug sales to rise to $50 billion by 2020, predicts PwC
This article was originally published in Scrip
Executive Summary
India's domestic and export pharmaceutical sales are projected to rise to about $50 billion by 2020 (assuming a CAGR of 9.2%), a 163% increase in the space of 11 years from the current $19 billion in March 2009, says a new report by PricewaterhouseCoopers (PwC).